By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – In the midst of reporting a 38 percent drop in revenues year over year, Pressure BioSciences today said that at current cash levels, it can maintain its business only through the end of the second quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.